+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Targeting Signaling Pathways in Solid Tumors Part C. International Review of Cell and Molecular Biology Volume 389

  • Book

  • October 2024
  • Region: Global
  • Elsevier Science and Technology
  • ID: 5994700

Targeting Signaling Pathways in Solid Tumors, Part C, Volume 389 in the International Review of Cell and Molecular Biology series, highlights new advances in the field, with this new volume presenting interesting chapters on topics such as Drugging the Undruggable: Advances in Targeting KRAS Signaling in Solid Tumors, Emerging Trends in Gastrointestinal Cancers: Targeting Developmental Pathways in their Carcinogenesis and Tumor Progression, Importance of targeting various cell signaling pathways in solid cancers, Targeting signaling pathways in cancer stem cells: a potential approach for developing novel anticancer therapeutics, Factors affecting heterogeneity in breast cancer microenvironment: A narrative review, and much more.

Additional sections cover Exploring TLR Signaling Pathways as Promising Targets in Cervical Cancer: The Road Less Travelled

Please Note: This is an On Demand product, delivery may take up to 11 working days after payment has been received.

Table of Contents

1. Multifaceted perspectives of detecting and targeting solid tumors
Anjan Dasgupta and Abhishek Bhattacharya
2. Tumor microenvironment induced switch to mitochondrial metabolism promotes suppressive functions in immune cells.
Vandana Anang, Sanjay Pandey and Michelle Schumaker
3. DNA damage response (DDR) and neoantigens: A favorable target for triple negative breast cancer (TNBC) immunotherapy and vaccine development
Nityanand Srivastava
4. Role of Interferon Dependent and Independent Signaling pathways: Implications in Cancer
Sheila Spada and Dr Anirban Ganguly
5. Immunological Landscape of Solid Cancer: Interplay Between Tumor and Immune System
Nitin Amdare
6. Targeting mTOR signaling in solid tumors
Vipin Rawat, SOUNAK Ghosh Roy and Subhajit Chatterjee
7. Unraveling the Molecular Basis of PARP Inhibitor Resistance in Prostate Cancer with Homologous Recombination Repair Deficiency
Goutam Chakraborty